Last update :
06/05/2021
Stability and compatibility of drugs
Welcome in Stabilis. If you wish to receive the quarterly newsletter, indicate your email address. Sign up

If you have any questions or comments, please contact : infostab@stabilis.org
Database  
References : 2499
Compounds : 804
Pharmacological Class : 46
Stability of solutions : 5845
Stability in mixtures : 1181
Incompatibilities : 11787
Trade Name : 4505
News - Compounds  
Anticoagulant Injection Nafamostat 19/04/2021
Hormone Injection Thiamazole 09/03/2021
Anxiolytic Capsule Midazolam hydrochloride 03/03/2021
Various Injection Turoctocog alfa 03/03/2021
Antibiotic Injection Cefiderocol sulfate tosylate 03/03/2021
Anti-arrhythmic Injection Flecainide acetate 04/12/2020
Antibiotic Injection Cefotiam 04/12/2020
Various Oral solution Carbimazole 01/12/2020
Anticancer drug Injection Durvalumab 25/11/2020
Antibiotic Injection Imipenem-Cilastatin / Relebactam 12/11/2020
Anticancer drug Injection Avelumab 04/11/2020
Antibiotic Injection Meropenem Vaborbactam 06/09/2020
Analgesic Injection Dezocine 05/09/2020
Various Injection L-carnitine 05/09/2020
Antibiotic Injection Eravacycline 05/09/2020
Anti-inflammatory Oral solution Hydrocortisone sodium succinate 21/07/2020
Various Injection Glycerophosphate disodium 11/06/2020
Antifungal Injection Posaconazole 11/06/2020
Antibiotic Oral solution Cloxacilline 03/06/2020
Antifungal Oral solution Griseofulvine 03/06/2020
News - References  
Date of Entry
4545 Physical compatibility of nafamostat with analgesics, sedatives, and muscle relaxants for coronavirus disease treatment. Journal of Nippon Medical school 22/03/2021
4532 Atezolizumab (Tecentriq®) - Summary of Product Characteristics Roche Products Limited 25/02/2021
4529 Arsenic trioxide - Summary of Product Characteristics Accord Healthcare S.L.U. 23/02/2021
4528 Physical Compatibility of Cefiderocol with Selected Intravenous Drugs During Simulated Y-site Administration. Int J Pharm Compound 12/02/2021
4526 Stability of mitomycin in polypropylene syringes for use in glaucoma surgery. EJOP 02/02/2021
4525 Evaluation of the Physico-Chemical and Biological Stability of SB8 (Aybintio), a Proposed Biosimilar to Bevacizumab, Under Ambient and In-Use Conditions. Adv Ther 28/01/2021
4523 Formulation and stability study of hydroxychloroquine sulfate oral suspensions. Pharm Dev Technol 20/01/2021
4524 Physical compatibility of the propofol emulsion with 33 drugs used in anaesthesiology. ESCP Symposium, Geneva, Switzerland 20/01/2021
4522 Six months stability investigation of sufentanil and ropivacaine/levobupivacaine admixtures in plastic container by LC-UV. J Pharm Biomed Anal 19/01/2021
4521 Compatibility of injectable posaconazole with drugs commonly used in a hematology care unit. Pharmaceutical Technology in Hospital Pharmacy 12/01/2021
4518 In-use stability of diluted thiamazole (methimazole) infusion solutions in prefilled 0.9% sodium chloride infusion bags for continuous infusion. EJHP 06/01/2021
4520 Physicochemical stability of compounded midazolam capsules over a one-year storage period. Pharmaceutical Technology in Hospital Pharmacy 06/01/2021
4515 Co-Administration of Drugs and Parenteral Nutrition: In Vitro Compatibility Studies of Loop Diuretics for Safer Clinical Practice. Pharmaceutics 16/12/2020
4516 Physicochemical stability of the bevacizumab biosimilar, ABP 215, after preparation and storage in intravenous bags. GaBI Journal 16/12/2020
4512 Assessment of the stability of citrate- buffered piperacillin/tazobactam for continuous infusion when stored in two commercially available elastomeric devices for outpatient parenteral antimicrobial chemotherapy: a study compliant with the NHS Yellow Cover Document requirements EJHP 08/12/2020
4506 Physical compatibility of milrinone 1 mg/mL with select cardiovascular medications during simulated Y-site administration. Am J Health-Syst Pharm 07/12/2020
4507 Compatibility of medications with intravenous lipid emulsions: Effects of simulated Y-site mixing. Am J Health-Syst Pharm 07/12/2020
4510 Stability studies of parenteral nutrition with a high dose of vitamin C. J Oncol Pharm Practice 07/12/2020
4511 Nivolumab (Opdivo®) - Summary of Product Characteristics Bristol Myers Squibb Pharmaceuticals 07/12/2020
4505 Stability of nivolumab in its original vials after opening and handing in normal saline bag for intravenous infusion. Eur J Cancer 27/11/2020
4500 Stability of Extemporaneously Prepared Acetazolamide Oral Suspensions at Two Temperatures. J Pediatr Pharmacol Ther 23/11/2020
4501 The effect of concentration, reconstitution solution and pH on the stability of a remifentanil hydrochloride and propofol admixture for simultaneous co-infusion. BMC Anesthesiology 23/11/2020
4502 Stability of Turoctocog Alfa, a Recombinant Factor VIII Product, during Continuous Infusion In Vitro. TH Open 23/11/2020
4503 Ziconotide (Prialt®) - Summary of Product Characteristics RIEMSER Pharma GmbH 23/11/2020
4498 Development and validation of a new HPLC method for the analysis of a novel oral suspension formulation of 50 mg/mL ursodesoxycholic acid for newborns. Pharmaceutical Technology in Hospital Pharmacy 19/11/2020
4499 Stability evaluation of an extemporaneously compounded carbimazole oral suspension. J Pharm Pract and Res 19/11/2020
4496 Stability Study of Admixtures Combining Ziconotide With Morphine or Sufentanil in Polypropylene Syringes. Neuromodulation 17/11/2020
4493 Physicochemical stability study of MYL-1401O, a biosimilar of trastuzumab, following a transient temperature excursion. J Oncol Pharm Practice 12/11/2020
4494 Long-term stability of cetuximab - Personal communication to INFOSTAB, November 12, 2020. Merck 12/11/2020
4491 Physical compatibility of alprostadil with selected drugs commonly used in the neonatal intensive care units. Eur J Pedia 03/11/2020

  Mentions Légales